| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | — | +0.0% |
| R&D Expense | $16.2M | — | +2.3% |
| SG&A Expense | $8.1M | — | +34.4% |
| Operating Income | -$24.2M | — | -11.1% |
| Pre-tax Income | -$22.6M | — | -11.4% |
| Income Tax | -$681K | — | +0.0% |
| Net Income | -$22.6M | — | -15.3% |
| EPS (Basic) | -$0.18 | — | +30.8% |
| EPS (Diluted) | -$0.18 | — | +30.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $97.6M | +123.0% | +98.8% |
| Short-term Investments | $233.9M | +1.8% | +132.3% |
| Accounts Receivable | $1.7M | +36.6% | +228.4% |
| Current Assets | $334.7M | +20.3% | +115.6% |
| Total Assets | $335.6M | +19.9% | +113.4% |
| Current Liabilities | $11.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.9M | — | -24.4% |
| Capital Expenditures | $21K | — | — |
| Investing Cash Flow | -$3.7M | — | +27.7% |
| Financing Cash Flow | $78.5M | — | +130.0% |
| Free Cash Flow | -$21.0M | — | — |
| +15.6% |
| Long-term Debt | $34.5M | +0.6% | — |
| Total Liabilities | $51.6M | -6.2% | +242.0% |
| Stockholders' Equity | $284.0M | +26.3% | +99.8% |